Lombard Odier Asset Management (Switzerland)’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Lombard Odier Asset Management (Switzerland)’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-314,862	Closed	-$7.59M	–	399
2023 Q1	$7.59M	Sell	314,862 -8,033	-2%	-$101K	0.66%	43
2022 Q4	$3.41M	Buy	+322,895	New	+$2.61M	0.27%	79

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s PRVB Position: Q2 2023 in Review

Lombard Odier Asset Management (Switzerland) sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 314,862 shares — an estimated $7.59M sold.

Lombard Odier Asset Management (Switzerland) first reported a position in PRVB in Q4 2022 and held it in 2 quarters. The position peaked at $7.59M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Lombard Odier Asset Management (Switzerland) reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Lombard Odier Asset Management (Switzerland) sold 314,862 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $7.59M.
Lombard Odier Asset Management (Switzerland) first reported a position in Provention Bio, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
Lombard Odier Asset Management (Switzerland)'s Provention Bio, Inc. Common Stock position peaked at $7.59M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 14 Aug 2023.